Literature DB >> 23328525

Mortality by level of emphysema and airway wall thickness.

Ane Johannessen1, Trude Duelien Skorge, Matteo Bottai, Thomas Blix Grydeland, Roy Miodini Nilsen, Harvey Coxson, Asger Dirksen, Ernst Omenaas, Amund Gulsvik, Per Bakke.   

Abstract

RATIONALE: There is limited knowledge of the prognostic value of quantitative computed tomography (CT) measures of emphysema and airway wall thickness (AWT) on mortality.
OBJECTIVES: To examine 8-year mortality in relation to CT-measured emphysema and AWT, and assess if potential impact of these predictors remained after adjustment for lung function.
METHODS: In the Norwegian GenKOLS study of 2003-2005, 947 ever-smokers (49% with COPD) aged 40-85 years performed spirometry and CT examination. Mortality data from 2003-2011 were gathered from the Norwegian Cause of Death Registry. CT emphysema % low-attenuation areas (%LAA) and standardized measure for AWT (AWT-Pi10) were main predictors. We performed Laplace regression for survival data, estimating survival time for specified population percentiles within each emphysema category. Models were adjusted for sex, FEV1, COPD status, age, body mass index, smoking, and inflation level.
MEASUREMENTS AND MAIN RESULTS: During 8-year follow-up all-cause mortality rate was 15%. Although 4% of the subjects with %LAA less than 3 died, 18% with %LAA 3-10 and 44% with %LAA greater than or equal to 10 died. After adjustment, the comparable percentile subjects with medium and high emphysema had 19 months shorter survival than subjects who died in the lowest emphysema category. Subjects with %LAA greater than or equal to 10 had 33 and 37 months shorter survival than the lowest emphysema category with regard to respiratory and cardiovascular mortality, respectively. No significant associations were found between %LAA and cancer and lung cancer mortality. AWT did not predict mortality independently, but a positive interaction with emphysema was observed.
CONCLUSIONS: AWT affected mortality with increasing degree of emphysema, whereas CT measure of emphysema was a strong independent mortality predictor.

Entities:  

Mesh:

Year:  2013        PMID: 23328525     DOI: 10.1164/rccm.201209-1722OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  91 in total

1.  Deep neural network analyses of spirometry for structural phenotyping of chronic obstructive pulmonary disease.

Authors:  Sandeep Bodduluri; Arie Nakhmani; Joseph M Reinhardt; Carla G Wilson; Merry-Lynn McDonald; Ramaraju Rudraraju; Byron C Jaeger; Nirav R Bhakta; Peter J Castaldi; Frank C Sciurba; Chengcui Zhang; Purushotham V Bangalore; Surya P Bhatt
Journal:  JCI Insight       Date:  2020-07-09

2.  Machine Learning and Prediction of All-Cause Mortality in COPD.

Authors:  Matthew Moll; Dandi Qiao; Elizabeth A Regan; Gary M Hunninghake; Barry J Make; Ruth Tal-Singer; Michael J McGeachie; Peter J Castaldi; Raul San Jose Estepar; George R Washko; James M Wells; David LaFon; Matthew Strand; Russell P Bowler; MeiLan K Han; Jorgen Vestbo; Bartolome Celli; Peter Calverley; James Crapo; Edwin K Silverman; Brian D Hobbs; Michael H Cho
Journal:  Chest       Date:  2020-04-27       Impact factor: 9.410

Review 3.  Updates in Chronic Obstructive Pulmonary Disease for the Year 2014.

Authors:  Sibel Atış Naycı; Lütfi Çöplü; Alev Gürgün; Nurdan Köktürk; Mehmet Polatlı; Elif Şen; Sema Umut; Esra Uzaslan; Nurhayat Yıldırım; Peter J Barnes
Journal:  Turk Thorac J       Date:  2015-04-01

4.  Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort.

Authors:  Joseph K Leader; Kristina Crothers; Laurence Huang; Mark A King; Alison Morris; Bruce W Thompson; Sonia C Flores; Michael B Drummond; William N Rom; Philip T Diaz
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

5.  Biomechanical CT metrics are associated with patient outcomes in COPD.

Authors:  Sandeep Bodduluri; Surya P Bhatt; Eric A Hoffman; John D Newell; Carlos H Martinez; Mark T Dransfield; Meilan K Han; Joseph M Reinhardt
Journal:  Thorax       Date:  2017-01-02       Impact factor: 9.139

6.  Inter- and intra-software reproducibility of computed tomography lung density measurements.

Authors:  Miranda Kirby; Charles Hatt; Nancy Obuchowski; Stephen M Humphries; Jered Sieren; David A Lynch; Sean B Fain
Journal:  Med Phys       Date:  2020-03-31       Impact factor: 4.071

7.  Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study.

Authors:  Eric A Hoffman; Firas S Ahmed; Heather Baumhauer; Mathew Budoff; J Jeffrey Carr; Richard Kronmal; S Reddy; R Graham Barr
Journal:  Ann Am Thorac Soc       Date:  2014-07

Review 8.  Cannabis Smoking in 2015: A Concern for Lung Health?

Authors:  Jason R Biehl; Ellen L Burnham
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

9.  Looking at the Airway to Understand Interstitial Lung Disease.

Authors:  Justin M Oldham
Journal:  Ann Am Thorac Soc       Date:  2019-04

Review 10.  The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease.

Authors:  Wassim W Labaki; Carlos H Martinez; Fernando J Martinez; Craig J Galbán; Brian D Ross; George R Washko; R Graham Barr; Elizabeth A Regan; Harvey O Coxson; Eric A Hoffman; John D Newell; Douglas Curran-Everett; James C Hogg; James D Crapo; David A Lynch; Ella A Kazerooni; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.